Cargando…
Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most frequent malignancies. Alpha-fetoprotein (AFP) has some limitations in diagnosing early HCC. Recently, long noncoding RNAs (lncRNAs) showed great potential as tumor diagnostic biomarkers, and lnc-MyD88 was previously identified as a carci...
Autores principales: | Wang, Zhihuai, Gao, Peng, Sun, Weijun, Rehman, Adeel ur, Jiang, Jiakai, Xu, Suobao, Xue, Cailin, Zhu, Chunfu, Qin, Xihu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922760/ https://www.ncbi.nlm.nih.gov/pubmed/36793272 http://dx.doi.org/10.3389/fendo.2023.938102 |
Ejemplares similares
-
PI3K/AKT/mTOR Pathway-Associated Genes Reveal a Putative Prognostic Signature Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Wang, Zhihuai, et al.
Publicado: (2022) -
Necroptosis of nucleus pulposus cells involved in intervertebral disc degeneration through MyD88 signaling
por: Fan, Hong, et al.
Publicado: (2022) -
MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity
por: Saikh, Kamal U.
Publicado: (2021) -
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
por: Luo, Wu, et al.
Publicado: (2022) -
A MyD88 meddles with survival
por: Bashyam, Hema
Publicado: (2007)